Open access · OA
via OpenAlex
Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes
Roberto Vettor, Roberto Serra, Roberto Fabris, Claudio Pagano, Giovanni Federspil
Diabetes Care · 2005 · ▲ 103 citations
Abstract
OBJECTIVE: The aim of this study was to provide a comprehensive meta-analysis of randomized controlled clinical studies on the effects of sibutramine on weight loss and glycemic control in obese subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS: Controlled clinical trials assessing the effect sizes of sibutramine on weight loss effects on glycemia in obese subjects with type 2 diabetes were identified and reviewed using the Cochrane Library, Medline, EMBASE, and a manual search. RESULTS: Eight placebo-controlled, double-blind, randomized trials of sibutramine were included. After sibutramine treatment, the decrease in body weight and waist circumference was significantly greater than in the placebo group. Fasting blood glucose and HbA(1c) significantly decreased after sibutramine treatment. Treatment benefits were seen in plasma triglycerides and HDL, without significant variations in serum total and LDL cholesterol. No differences in systolic blood pressure between the sibutramine and the placebo groups were seen, while recording of diastolic blood pressure and heart rate showed that sibutramine produced a small increase relative to placebo. CONCLUSIONS: A pharmacological approach in a weight management program for patients with type 2 diabetes may be helpful in glycemic control and in the management of other risk factors. Sibutramine may help improve glucose control because it is conducive to weight loss. The reviewed data on the effect of sibutramine further enforce the recommendations that weight management may be the most important therapeutic task for most obese subjects with type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/diacare.28.4.942
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Vettor, R., Serra, R., Fabris, R., Pagano, C., & Federspil, G. (2005). Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes. <em>Diabetes Care</em>. https://doi.org/10.2337/diacare.28.4.942
Vancouver
Vettor R, Serra R, Fabris R, Pagano C, Federspil G. Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes. Diabetes Care. 2005. doi:10.2337/diacare.28.4.942.
BibTeX
@article{roberto2005Effect,
title = {Effect of Sibutramine on Weight Management and Metabolic Control in Type 2 Diabetes},
author = {Roberto Vettor and Roberto Serra and Roberto Fabris and Claudio Pagano and Giovanni Federspil},
journal = {Diabetes Care},
year = {2005},
doi = {10.2337/diacare.28.4.942},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental and Therapeutic Medicine 2016
Open access · OA
Therapeutic effects of soluble dietary fiber consumption on type 2 diabetes mellitus
Medical Journal of the Chinese People's Armed Police Forces 2006
Citation only
Metabolic impact of body weight variation on old age type 2 diabetes mellitus
International Journal of Endocrinology 2020
Open access · CC-BY
Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis
Diabetes Care 2009
Open access · CC-BY
Impact of Metabolic Syndrome Compared With Impaired Fasting Glucose on the Development of Type 2 Diabetes in a General Japanese Population
JAMA Network Open 2021
Open access · CC-BY
Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes
Diabetes Obesity and Metabolism 2000
Open access · OA